Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 2 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Alx Oncology Holdings Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 96 | 2 | 97 | +3 |
| Shares | 36.8M | 25.0K | 35.9M | −838.2K (−2.3%) |
| Value | $621.9M | $423.0K | $290.7M | −$330.8M (−53.2%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Alx Oncology Holdings Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| ExodusPoint Capital Management, LP | 187,258 | $1.51M | 0.02% |
| PDT Partners, LLC | 102,696 | $831.0K | 0.07% |
| Los Angeles Capital Management LLC | 98,964 | $801.0K | 0.00% |
| HRT Financial LP | 86,470 | $699.0K | 0.01% |
| Qube Research & Technologies Ltd | 86,098 | $697.0K | 0.01% |
| Ergoteles LLC | 66,600 | $539.0K | 0.02% |
| Martingale Asset Management L P | 41,933 | $340.0K | 0.01% |
| Prudential Financial Inc | 38,090 | $308.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 34,386 | $278.0K | 0.00% |
| New York Life Investment Management LLC | 27,594 | $223.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 26,564 | $214.0K | 0.00% |
| Trexquant Investment LP | 22,211 | $180.0K | 0.01% |
| Acadian Asset Management LLC | 20,955 | $170.0K | 0.00% |
| Bailard, Inc. | 15,510 | $125.0K | 0.00% |
| Delphia (USA) Inc. | 10,119 | $82.0K | 0.06% |
| Bradley & Co. Private Wealth Management, LLC | 1,000 | $8.00K | 0.01% |
| Bell Investment Advisors, Inc | 88 | $1.00K | 0.00% |
| Northwestern Mutual Wealth Management Co | 48 | $0 | 0.00% |
Sold out (15)
Institutions that held Alx Oncology Holdings Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Invesco Ltd. | 643,487 | $10.9M |
| Rafferty Asset Management, LLC | 156,876 | $2.65M |
| AXA S.A. | 124,199 | $2.10M |
| UBS Group AG | 86,072 | $1.46M |
| Vident Investment Advisory, LLC | 50,123 | $847.0K |
| NinePointTwo Capital | 14,257 | $240.0K |
| Squarepoint Ops LLC | 13,189 | $223.0K |
| MetLife Investment Management | 10,745 | $181.6K |
| Stifel Financial Corp | 10,150 | $172.0K |
| Metropolitan Life Insurance Co | 1,242 | $21.0K |
| US Bancorp | 577 | $9.00K |
| State of Wyoming | 303 | $5.00K |
| Signaturefd, LLC | 130 | $2.00K |
| Bessemer Group Inc | 68 | $1.00K |
| Allworth Financial LP | 10 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held Alx Oncology Holdings Inc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| IndexIQ Advisors LLC | 22,127 | $374.0K |
| Amalgamated Financial Corp. | 2,898 | $49.0K |